A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease
PHASE1CompletedINTERVENTIONAL
Enrollment
54
Participants
Timeline
Start Date
July 18, 2019
Primary Completion Date
May 11, 2021
Study Completion Date
May 11, 2021
Conditions
Chronic Kidney Disease
Interventions
DRUG
DDO-3055
Oral
DRUG
Placebos
Oral
Trial Locations (1)
Unknown
Guangdong Provincial People's Hospital, Guangzhou
All Listed Sponsors
lead
Jiangsu HengRui Medicine Co., Ltd.
INDUSTRY
NCT03976115 - A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter